Andreas C. Joerger

8.2k total citations · 3 hit papers
68 papers, 6.3k citations indexed

About

Andreas C. Joerger is a scholar working on Molecular Biology, Oncology and Materials Chemistry. According to data from OpenAlex, Andreas C. Joerger has authored 68 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 40 papers in Oncology and 9 papers in Materials Chemistry. Recurrent topics in Andreas C. Joerger's work include Cancer-related Molecular Pathways (39 papers), Epigenetics and DNA Methylation (17 papers) and RNA modifications and cancer (17 papers). Andreas C. Joerger is often cited by papers focused on Cancer-related Molecular Pathways (39 papers), Epigenetics and DNA Methylation (17 papers) and RNA modifications and cancer (17 papers). Andreas C. Joerger collaborates with scholars based in United Kingdom, Germany and United States. Andreas C. Joerger's co-authors include Alan R. Fersht, Frank M. Boeckler, Rainer Wilcken, Alan R. Fersht, Markus O. Zimmermann, Andreas Lange, A.R. Fersht, Dmitry B. Veprintsev, Trevor J. Rutherford and Matthias R. Bauer and has published in prestigious journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Andreas C. Joerger

68 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology

2012 1.1k citations Andreas C. Joerger, Frank M. Boeckler et al. Journal of Medicinal Chemistry profile →
Structural Biology of the Tumor Suppressor p53

2008 524 citations Andreas C. Joerger, Alan R. Fersht profile →
The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches

2016 477 citations Andreas C. Joerger, Alan R. Fersht profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andreas C. Joerger United Kingdom	37	4.4k	2.8k	862	672	594	68	6.3k
Andrew J. Wilson United Kingdom	50	5.2k 1.2×	1.4k 0.5×	2.9k 3.4×	1.1k 1.6×	448 0.8×	172	8.4k
David W. Banner Switzerland	45	4.2k 0.9×	738 0.3×	2.2k 2.5×	1.0k 1.6×	441 0.7×	103	9.1k
John W. Kozarich United States	43	5.2k 1.2×	1.7k 0.6×	1.9k 2.3×	910 1.4×	391 0.7×	141	7.7k
A. Tulinsky United States	48	4.3k 1.0×	670 0.2×	815 0.9×	1.6k 2.4×	1.2k 2.0×	143	8.2k
Jeanne A. Stuckey United States	51	7.1k 1.6×	2.0k 0.7×	1.8k 2.0×	674 1.0×	391 0.7×	142	9.9k
Sarah Cianférani France	44	4.9k 1.1×	1.2k 0.4×	673 0.8×	709 1.1×	256 0.4×	240	7.2k
William W. Bachovchin United States	41	2.3k 0.5×	1.6k 0.6×	596 0.7×	658 1.0×	443 0.7×	105	4.4k
Nicolas Winssinger Switzerland	59	6.9k 1.5×	760 0.3×	5.3k 6.1×	568 0.8×	389 0.7×	221	10.2k
R. Kiplin Guy United States	50	4.6k 1.0×	2.5k 0.9×	3.5k 4.0×	316 0.5×	372 0.6×	186	9.9k
Pascal Furet Switzerland	50	5.6k 1.3×	2.4k 0.9×	2.0k 2.3×	215 0.3×	602 1.0×	125	8.6k

Countries citing papers authored by Andreas C. Joerger

Since Specialization

Citations

This map shows the geographic impact of Andreas C. Joerger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas C. Joerger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas C. Joerger more than expected).

Fields of papers citing papers by Andreas C. Joerger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas C. Joerger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas C. Joerger. The network helps show where Andreas C. Joerger may publish in the future.

Co-authorship network of co-authors of Andreas C. Joerger

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas C. Joerger. A scholar is included among the top collaborators of Andreas C. Joerger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas C. Joerger. Andreas C. Joerger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Strubel, Alexander, Marco Mernberger, Christian Osterburg, et al.. (2025). DARPin-induced reactivation of p53 in HPV-positive cells. Nature Structural & Molecular Biology. 32(5). 790–801. 1 indexed citations

Krämer, Andreas, Tran Do Hoang Nhu, Andreas C. Joerger, et al.. (2024). Back-Pocket Optimization of 2-Aminopyrimidine-Based Macrocycles Leads to Potent EPHA2/GAK Kinase Inhibitors. Journal of Medicinal Chemistry. 67(15). 12534–12552. 8 indexed citations

Krämer, Andreas, et al.. (2024). Structural basis of p53 inactivation by cavity-creating cancer mutations and its implications for the development of mutant p53 reactivators. Cell Death and Disease. 15(6). 408–408. 7 indexed citations

Jones, Megan, Michael McCoy, Andreas C. Joerger, et al.. (2023). Structure–Reactivity Studies of 2-Sulfonylpyrimidines Allow Selective Protein Arylation. Bioconjugate Chemistry. 34(9). 1679–1687. 11 indexed citations

Zhang, Qiang, Bruno Baron, Tali E. Haran, et al.. (2022). Evolutionary history of the p53 family DNA-binding domain: insights from an Alvinella pompejana homolog. Cell Death and Disease. 13(3). 214–214. 14 indexed citations

Berger, Benedict‐Tilman, Martin Schröder, Deep Chatterjee, et al.. (2021). Development of a Selective Dual Discoidin Domain Receptor (DDR)/p38 Kinase Chemical Probe. Journal of Medicinal Chemistry. 64(18). 13451–13474. 5 indexed citations

Luparello, Claudio, Andreas C. Joerger, Cory A. Ocasio, et al.. (2021). Genotoxicity and Epigenotoxicity of Carbazole-Derived Molecules on MCF-7 Breast Cancer Cells. International Journal of Molecular Sciences. 22(7). 3410–3410. 5 indexed citations

Leroy, Bernard, Isabelle Martins, Johanna Sofia Margareta Mattsson, et al.. (2020). Identification and functional characterization of new missense SNPs in the coding region of the TP53 gene. Cell Death and Differentiation. 28(5). 1477–1492. 22 indexed citations

Schröder, Martin, Caroline S. Widdowson, A. Chaikuad, et al.. (2020). Selective targeting of the αC and DFG-out pocket in p38 MAPK. European Journal of Medicinal Chemistry. 208. 112721–112721. 20 indexed citations

10.

Bauer, Matthias R., Andreas Krämer, Giovanni Settanni, et al.. (2020). Targeting Cavity-Creating p53 Cancer Mutations with Small-Molecule Stabilizers: the Y220X Paradigm. ACS Chemical Biology. 15(3). 657–668. 49 indexed citations

11.

Zeinyeh, Waël, Stefan Knapp, Deep Chatterjee, et al.. (2019). New pyrido[3,4-g]quinazoline derivatives as CLK1 and DYRK1A inhibitors: synthesis, biological evaluation and binding mode analysis. European Journal of Medicinal Chemistry. 166. 304–317. 32 indexed citations

12.

Baud, Matthias G. J., Matthias R. Bauer, Lorena Verduci, et al.. (2018). Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines. European Journal of Medicinal Chemistry. 152. 101–114. 64 indexed citations

13.

Basse, Nicolas, Joel L. Kaar, Giovanni Settanni, et al.. (2010). Toward the Rational Design of p53-Stabilizing Drugs: Probing the Surface of the Oncogenic Y220C Mutant. Chemistry & Biology. 17(1). 46–56. 93 indexed citations

14.

Brandt, Tobias, et al.. (2010). Molecular basis of S100 proteins interacting with the p53 homologs p63 and p73. Oncogene. 29(14). 2024–2035. 46 indexed citations

15.

Kaar, Joel L., Nicolas Basse, Andreas C. Joerger, et al.. (2010). Stabilization of mutant p53 via alkylation of cysteines and effects on DNA binding. Protein Science. 19(12). 2267–2278. 60 indexed citations

16.

Boeckler, Frank M., et al.. (2008). Targeted rescue of a destabilized mutant of p53 by an in silico screened drug. Proceedings of the National Academy of Sciences. 105(30). 10360–10365. 304 indexed citations

17.

Joerger, Andreas C. & A.R. Fersht. (2007). Structure–function–rescue: the diverse nature of common p53 cancer mutants. Oncogene. 26(15). 2226–2242. 339 indexed citations

18.

Joerger, Andreas C., et al.. (2006). Effects of Common Cancer Mutations on Stability and DNA Binding of Full-length p53 Compared with Isolated Core Domains. Journal of Biological Chemistry. 281(31). 21934–21941. 118 indexed citations

19.

Joerger, Andreas C., et al.. (2005). Structures of p53 Cancer Mutants and Mechanism of Rescue by Second-site Suppressor Mutations. Journal of Biological Chemistry. 280(16). 16030–16037. 150 indexed citations

20.

Joerger, Andreas C., Mark D. Allen, & Alan R. Fersht. (2004). Crystal Structure of a Superstable Mutant of Human p53 Core Domain. Journal of Biological Chemistry. 279(2). 1291–1296. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact